1-4 of 4
Ryan Miller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma

Alexandre Chlenski, Chanyoung Park, Marija Dobratic, Helen R. Salwen, Brian Budke, Jae-Hyun Park, Ryan Miller, Mark A. Applebaum, Emma Wilkinson, Yusuke Nakamura, Philip P. Connell, Susan L. Cohn
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 507–516.
https://doi.org/10.1158/1535-7163.MCT-18-0819
Published: 01 March 2019
View article titled, Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
Open the PDF for Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract A03: Several rational combination kinase inhibitor treatments identified by synthetic lethality screens are efficacious in intracranial triple negative breast cancer models

Amanda E.D. Van Swearingen, Maria J. Sambade, Marni B. Siegel, Shivani Sud, Samantha M. Bevill, Brian T. Golitz, Ryan E. Bash, Charlene M. Santos, David B. Darr, Joel S. Parker, C. Ryan Miller, Gary L. Johnson, Carey K. Anders
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (10_Supplement): A03.
https://doi.org/10.1158/1538-8514.SYNTHLETH-A03
Published: 02 October 2017
View article titled, Abstract A03: Several rational combination kinase inhibitor treatments identified by synthetic lethality screens are efficacious in intracranial triple negative breast cancer models
Journal Articles

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA–Wild-Type Triple-Negative Breast Cancer

Olga Karginova, Marni B. Siegel, Amanda E.D. Van Swearingen, Allison M. Deal, Barbara Adamo, Maria J. Sambade, Soha Bazyar, Nana Nikolaishvili-Feinberg, Ryan Bash, Sara O'Neal, Katie Sandison, Joel S. Parker, Charlene Santos, David Darr, William Zamboni, Yueh Z. Lee, C. Ryan Miller, Carey K. Anders
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2015) 14 (4): 920–930.
https://doi.org/10.1158/1535-7163.MCT-14-0474
Published: 09 April 2015
View article titled, Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of <em>BRCA</em>-Mutated and <em>BRCA</em>–Wild-Type Triple-Negative Breast Cancer
Open the PDF for Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of <em>BRCA</em>-Mutated and <em>BRCA</em>–Wild-Type Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Induction of Thymidine Phosphorylase in Both Irradiated and Shielded, Contralateral Human U87MG Glioma Xenografts: Implications for a Dual Modality Treatment Using Capecitabine and Irradiation

Carmelo Blanquicett, G. Yancey Gillespie, L. Burt Nabors, C. Ryan Miller, Sumen Bharara, Donald J. Buchsbaum, Robert. B. Diasio, Martin R. Johnson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (12): 1139–1145.
Published: 01 October 2002
View article titled, Induction of Thymidine Phosphorylase in Both Irradiated and Shielded, Contralateral Human U87MG Glioma Xenografts: Implications for a Dual Modality Treatment Using Capecitabine and Irradiation
Open the PDF for Induction of Thymidine Phosphorylase in Both Irradiated and Shielded, Contralateral Human U87MG Glioma Xenografts: Implications for a Dual Modality Treatment Using Capecitabine and Irradiation in another window